Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 146 participants.

Also called NCT04591808

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 146 participants (enrolled count) (from the registry)
Sponsor
Institut de Recherches Internationales Servier (from the registry)
Registry
  • NCT NCT04591808
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Georgia, Russia, Ukraine (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04591808. Randomized; double masking; primary purpose treatment. Start 2021-09-09 (actual); primary completion 2022-04-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
Condition
Dyslipidemias
Condition
Hypertension
Intervention (Drug)
Atorvastatin/Perindopril
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Perindopril
Lead sponsor
Institut de Recherches Internationales Servier (class: other)
Collaborator
ADIR, a Servier Group company (class: industry)

Record details

Record id
cardio:ct-nct04591808
Content hash
0fd9490137ae334abb8f83ab4ad43a36b44d7fca693af3987983050d3409e84f